aluates Reports

$ 0.0

Automative

Global Neuroblastoma Treatment Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-1H2121

Global Neuroblastoma Treatment Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Neuroblastoma Treatment Market Research Report 2025

Code: QYRE-Auto-1H2121

Report

September 2025

Pages:82

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Seattle Children’s

CureSearch

Texas Children’s

NANT

Sino Biopharmaceutical

Jiangsu Hengrui Medicine Co Ltd

Fosun Pharmaceutical

Novartis

Juno Therapeutics

Kite Pharma

Adaptimmune

Neuroblastoma Treatment Market Size

The global market for Neuroblastoma Treatment was valued at US$ 476 million in the year 2024 and is projected to reach a revised size of US$ 603 million by 2031, growing at a CAGR of 3.5% during the forecast period.

Neuroblastoma Treatment Market

Neuroblastoma treatment includes medical interventions and therapies used to manage neuroblastoma, a type of cancer that affects the sympathetic nervous system, typically occurring in young children.

The market for neuroblastoma treatment is driven by the need for effective and personalized therapies to improve survival rates and long-term outcomes for pediatric cancer patients. The market"s growth is also influenced by ongoing research in neuroblastoma therapeutics and the development of targeted and immunotherapeutic approaches.

This report aims to provide a comprehensive presentation of the global market for Neuroblastoma Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuroblastoma Treatment.

The Neuroblastoma Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neuroblastoma Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Neuroblastoma Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Neuroblastoma Treatment Market Report

Report Metric	Details
Report Name	Neuroblastoma Treatment Market
Accounted market size in year	US$ 476 million
Forecasted market size in 2031	US$ 603 million
CAGR	3.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Combination Chemotherapy Monoclonal Antibody Therapy Vaccine Therapy Chimeric Antigen Receptor T-Cell Immunotherapy Oncolytic Virus Therapy
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Seattle Children’s, CureSearch, Texas Children’s, NANT, Sino Biopharmaceutical, Jiangsu Hengrui Medicine Co.,Ltd., Fosun Pharmaceutical, Novartis, Juno Therapeutics, Kite Pharma, Adaptimmune
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neuroblastoma Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Neuroblastoma Treatment Market growing?

Ans: The Neuroblastoma Treatment Market witnessing a CAGR of 3.5% during the forecast period 2025-2031.

What is the Neuroblastoma Treatment Market size in 2031?

Ans: The Neuroblastoma Treatment Market size in 2031 will be US$ 603 million.

Who are the main players in the Neuroblastoma Treatment Market report?

Ans: The main players in the Neuroblastoma Treatment Market are Seattle Children’s, CureSearch, Texas Children’s, NANT, Sino Biopharmaceutical, Jiangsu Hengrui Medicine Co.,Ltd., Fosun Pharmaceutical, Novartis, Juno Therapeutics, Kite Pharma, Adaptimmune

What are the Application segmentation covered in the Neuroblastoma Treatment Market report?

Ans: The Applications covered in the Neuroblastoma Treatment Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Neuroblastoma Treatment Market report?

Ans: The Types covered in the Neuroblastoma Treatment Market report are Combination Chemotherapy, Monoclonal Antibody Therapy, Vaccine Therapy, Chimeric Antigen Receptor T-Cell Immunotherapy, Oncolytic Virus Therapy

Recommended Reports

Neuro-oncology Treatments

Cancer Therapy Drugs

Pediatric Oncology

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Neuroblastoma Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Combination Chemotherapy

1.2.3 Monoclonal Antibody Therapy

1.2.4 Vaccine Therapy

1.2.5 Chimeric Antigen Receptor T-Cell Immunotherapy

1.2.6 Oncolytic Virus Therapy

1.3 Market by Application

1.3.1 Global Neuroblastoma Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Neuroblastoma Treatment Market Perspective (2020-2031)

2.2 Global Neuroblastoma Treatment Growth Trends by Region

2.2.1 Global Neuroblastoma Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Neuroblastoma Treatment Historic Market Size by Region (2020-2025)

2.2.3 Neuroblastoma Treatment Forecasted Market Size by Region (2026-2031)

2.3 Neuroblastoma Treatment Market Dynamics

2.3.1 Neuroblastoma Treatment Industry Trends

2.3.2 Neuroblastoma Treatment Market Drivers

2.3.3 Neuroblastoma Treatment Market Challenges

2.3.4 Neuroblastoma Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Neuroblastoma Treatment Players by Revenue

3.1.1 Global Top Neuroblastoma Treatment Players by Revenue (2020-2025)

3.1.2 Global Neuroblastoma Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Neuroblastoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Neuroblastoma Treatment Revenue

3.4 Global Neuroblastoma Treatment Market Concentration Ratio

3.4.1 Global Neuroblastoma Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Neuroblastoma Treatment Revenue in 2024

3.5 Global Key Players of Neuroblastoma Treatment Head office and Area Served

3.6 Global Key Players of Neuroblastoma Treatment, Product and Application

3.7 Global Key Players of Neuroblastoma Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Neuroblastoma Treatment Breakdown Data by Type

4.1 Global Neuroblastoma Treatment Historic Market Size by Type (2020-2025)

4.2 Global Neuroblastoma Treatment Forecasted Market Size by Type (2026-2031)

5 Neuroblastoma Treatment Breakdown Data by Application

5.1 Global Neuroblastoma Treatment Historic Market Size by Application (2020-2025)

5.2 Global Neuroblastoma Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Neuroblastoma Treatment Market Size (2020-2031)

6.2 North America Neuroblastoma Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Neuroblastoma Treatment Market Size by Country (2020-2025)

6.4 North America Neuroblastoma Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Neuroblastoma Treatment Market Size (2020-2031)

7.2 Europe Neuroblastoma Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Neuroblastoma Treatment Market Size by Country (2020-2025)

7.4 Europe Neuroblastoma Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Neuroblastoma Treatment Market Size (2020-2031)

8.2 Asia-Pacific Neuroblastoma Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Neuroblastoma Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Neuroblastoma Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Neuroblastoma Treatment Market Size (2020-2031)

9.2 Latin America Neuroblastoma Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Neuroblastoma Treatment Market Size by Country (2020-2025)

9.4 Latin America Neuroblastoma Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Neuroblastoma Treatment Market Size (2020-2031)

10.2 Middle East & Africa Neuroblastoma Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Neuroblastoma Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Neuroblastoma Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Seattle Children’s

11.1.1 Seattle Children’s Company Details

11.1.2 Seattle Children’s Business Overview

11.1.3 Seattle Children’s Neuroblastoma Treatment Introduction

11.1.4 Seattle Children’s Revenue in Neuroblastoma Treatment Business (2020-2025)

11.1.5 Seattle Children’s Recent Development

11.2 CureSearch

11.2.1 CureSearch Company Details

11.2.2 CureSearch Business Overview

11.2.3 CureSearch Neuroblastoma Treatment Introduction

11.2.4 CureSearch Revenue in Neuroblastoma Treatment Business (2020-2025)

11.2.5 CureSearch Recent Development

11.3 Texas Children’s

11.3.1 Texas Children’s Company Details

11.3.2 Texas Children’s Business Overview

11.3.3 Texas Children’s Neuroblastoma Treatment Introduction

11.3.4 Texas Children’s Revenue in Neuroblastoma Treatment Business (2020-2025)

11.3.5 Texas Children’s Recent Development

11.4 NANT

11.4.1 NANT Company Details

11.4.2 NANT Business Overview

11.4.3 NANT Neuroblastoma Treatment Introduction

11.4.4 NANT Revenue in Neuroblastoma Treatment Business (2020-2025)

11.4.5 NANT Recent Development

11.5 Sino Biopharmaceutical

11.5.1 Sino Biopharmaceutical Company Details

11.5.2 Sino Biopharmaceutical Business Overview

11.5.3 Sino Biopharmaceutical Neuroblastoma Treatment Introduction

11.5.4 Sino Biopharmaceutical Revenue in Neuroblastoma Treatment Business (2020-2025)

11.5.5 Sino Biopharmaceutical Recent Development

11.6 Jiangsu Hengrui Medicine Co.,Ltd.

11.6.1 Jiangsu Hengrui Medicine Co.,Ltd. Company Details

11.6.2 Jiangsu Hengrui Medicine Co.,Ltd. Business Overview

11.6.3 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Introduction

11.6.4 Jiangsu Hengrui Medicine Co.,Ltd. Revenue in Neuroblastoma Treatment Business (2020-2025)

11.6.5 Jiangsu Hengrui Medicine Co.,Ltd. Recent Development

11.7 Fosun Pharmaceutical

11.7.1 Fosun Pharmaceutical Company Details

11.7.2 Fosun Pharmaceutical Business Overview

11.7.3 Fosun Pharmaceutical Neuroblastoma Treatment Introduction

11.7.4 Fosun Pharmaceutical Revenue in Neuroblastoma Treatment Business (2020-2025)

11.7.5 Fosun Pharmaceutical Recent Development

11.8 Novartis

11.8.1 Novartis Company Details

11.8.2 Novartis Business Overview

11.8.3 Novartis Neuroblastoma Treatment Introduction

11.8.4 Novartis Revenue in Neuroblastoma Treatment Business (2020-2025)

11.8.5 Novartis Recent Development

11.9 Juno Therapeutics

11.9.1 Juno Therapeutics Company Details

11.9.2 Juno Therapeutics Business Overview

11.9.3 Juno Therapeutics Neuroblastoma Treatment Introduction

11.9.4 Juno Therapeutics Revenue in Neuroblastoma Treatment Business (2020-2025)

11.9.5 Juno Therapeutics Recent Development

11.10 Kite Pharma

11.10.1 Kite Pharma Company Details

11.10.2 Kite Pharma Business Overview

11.10.3 Kite Pharma Neuroblastoma Treatment Introduction

11.10.4 Kite Pharma Revenue in Neuroblastoma Treatment Business (2020-2025)

11.10.5 Kite Pharma Recent Development

11.11 Adaptimmune

11.11.1 Adaptimmune Company Details

11.11.2 Adaptimmune Business Overview

11.11.3 Adaptimmune Neuroblastoma Treatment Introduction

11.11.4 Adaptimmune Revenue in Neuroblastoma Treatment Business (2020-2025)

11.11.5 Adaptimmune Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Seattle Children’s

CureSearch

Texas Children’s

NANT

Sino Biopharmaceutical

Jiangsu Hengrui Medicine Co Ltd

Fosun Pharmaceutical

Novartis

Juno Therapeutics

Kite Pharma

Adaptimmune

List of Tables

Table 1. Global Neuroblastoma Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Combination Chemotherapy

Table 3. Key Players of Monoclonal Antibody Therapy

Table 4. Key Players of Vaccine Therapy

Table 5. Key Players of Chimeric Antigen Receptor T-Cell Immunotherapy

Table 6. Key Players of Oncolytic Virus Therapy

Table 7. Global Neuroblastoma Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Neuroblastoma Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Neuroblastoma Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Neuroblastoma Treatment Market Share by Region (2020-2025)

Table 11. Global Neuroblastoma Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Neuroblastoma Treatment Market Share by Region (2026-2031)

Table 13. Neuroblastoma Treatment Market Trends

Table 14. Neuroblastoma Treatment Market Drivers

Table 15. Neuroblastoma Treatment Market Challenges

Table 16. Neuroblastoma Treatment Market Restraints

Table 17. Global Neuroblastoma Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Neuroblastoma Treatment Market Share by Players (2020-2025)

Table 19. Global Top Neuroblastoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroblastoma Treatment as of 2024)

Table 20. Ranking of Global Top Neuroblastoma Treatment Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Neuroblastoma Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Neuroblastoma Treatment, Headquarters and Area Served

Table 23. Global Key Players of Neuroblastoma Treatment, Product and Application

Table 24. Global Key Players of Neuroblastoma Treatment, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Neuroblastoma Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Neuroblastoma Treatment Revenue Market Share by Type (2020-2025)

Table 28. Global Neuroblastoma Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Neuroblastoma Treatment Revenue Market Share by Type (2026-2031)

Table 30. Global Neuroblastoma Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Neuroblastoma Treatment Revenue Market Share by Application (2020-2025)

Table 32. Global Neuroblastoma Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Neuroblastoma Treatment Revenue Market Share by Application (2026-2031)

Table 34. North America Neuroblastoma Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Neuroblastoma Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Neuroblastoma Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Neuroblastoma Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Neuroblastoma Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Neuroblastoma Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Neuroblastoma Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Neuroblastoma Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Neuroblastoma Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Neuroblastoma Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Neuroblastoma Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Neuroblastoma Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Neuroblastoma Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Neuroblastoma Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Neuroblastoma Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 49. Seattle Children’s Company Details

Table 50. Seattle Children’s Business Overview

Table 51. Seattle Children’s Neuroblastoma Treatment Product

Table 52. Seattle Children’s Revenue in Neuroblastoma Treatment Business (2020-2025) & (US$ Million)

Table 53. Seattle Children’s Recent Development

Table 54. CureSearch Company Details

Table 55. CureSearch Business Overview

Table 56. CureSearch Neuroblastoma Treatment Product

Table 57. CureSearch Revenue in Neuroblastoma Treatment Business (2020-2025) & (US$ Million)

Table 58. CureSearch Recent Development

Table 59. Texas Children’s Company Details

Table 60. Texas Children’s Business Overview

Table 61. Texas Children’s Neuroblastoma Treatment Product

Table 62. Texas Children’s Revenue in Neuroblastoma Treatment Business (2020-2025) & (US$ Million)

Table 63. Texas Children’s Recent Development

Table 64. NANT Company Details

Table 65. NANT Business Overview

Table 66. NANT Neuroblastoma Treatment Product

Table 67. NANT Revenue in Neuroblastoma Treatment Business (2020-2025) & (US$ Million)

Table 68. NANT Recent Development

Table 69. Sino Biopharmaceutical Company Details

Table 70. Sino Biopharmaceutical Business Overview

Table 71. Sino Biopharmaceutical Neuroblastoma Treatment Product

Table 72. Sino Biopharmaceutical Revenue in Neuroblastoma Treatment Business (2020-2025) & (US$ Million)

Table 73. Sino Biopharmaceutical Recent Development

Table 74. Jiangsu Hengrui Medicine Co.,Ltd. Company Details

Table 75. Jiangsu Hengrui Medicine Co.,Ltd. Business Overview

Table 76. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Product

Table 77. Jiangsu Hengrui Medicine Co.,Ltd. Revenue in Neuroblastoma Treatment Business (2020-2025) & (US$ Million)

Table 78. Jiangsu Hengrui Medicine Co.,Ltd. Recent Development

Table 79. Fosun Pharmaceutical Company Details

Table 80. Fosun Pharmaceutical Business Overview

Table 81. Fosun Pharmaceutical Neuroblastoma Treatment Product

Table 82. Fosun Pharmaceutical Revenue in Neuroblastoma Treatment Business (2020-2025) & (US$ Million)

Table 83. Fosun Pharmaceutical Recent Development

Table 84. Novartis Company Details

Table 85. Novartis Business Overview

Table 86. Novartis Neuroblastoma Treatment Product

Table 87. Novartis Revenue in Neuroblastoma Treatment Business (2020-2025) & (US$ Million)

Table 88. Novartis Recent Development

Table 89. Juno Therapeutics Company Details

Table 90. Juno Therapeutics Business Overview

Table 91. Juno Therapeutics Neuroblastoma Treatment Product

Table 92. Juno Therapeutics Revenue in Neuroblastoma Treatment Business (2020-2025) & (US$ Million)

Table 93. Juno Therapeutics Recent Development

Table 94. Kite Pharma Company Details

Table 95. Kite Pharma Business Overview

Table 96. Kite Pharma Neuroblastoma Treatment Product

Table 97. Kite Pharma Revenue in Neuroblastoma Treatment Business (2020-2025) & (US$ Million)

Table 98. Kite Pharma Recent Development

Table 99. Adaptimmune Company Details

Table 100. Adaptimmune Business Overview

Table 101. Adaptimmune Neuroblastoma Treatment Product

Table 102. Adaptimmune Revenue in Neuroblastoma Treatment Business (2020-2025) & (US$ Million)

Table 103. Adaptimmune Recent Development

Table 104. Research Programs/Design for This Report

Table 105. Key Data Information from Secondary Sources

Table 106. Key Data Information from Primary Sources

Table 107. Authors List of This Report

List of Figures

Figure 1. Neuroblastoma Treatment Picture

Figure 2. Global Neuroblastoma Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Neuroblastoma Treatment Market Share by Type: 2024 VS 2031

Figure 4. Combination Chemotherapy Features

Figure 5. Monoclonal Antibody Therapy Features

Figure 6. Vaccine Therapy Features

Figure 7. Chimeric Antigen Receptor T-Cell Immunotherapy Features

Figure 8. Oncolytic Virus Therapy Features

Figure 9. Global Neuroblastoma Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Neuroblastoma Treatment Market Share by Application: 2024 VS 2031

Figure 11. Hospitals Case Studies

Figure 12. Clinics Case Studies

Figure 13. Others Case Studies

Figure 14. Neuroblastoma Treatment Report Years Considered

Figure 15. Global Neuroblastoma Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Neuroblastoma Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Neuroblastoma Treatment Market Share by Region: 2024 VS 2031

Figure 18. Global Neuroblastoma Treatment Market Share by Players in 2024

Figure 19. Global Top Neuroblastoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroblastoma Treatment as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Neuroblastoma Treatment Revenue in 2024

Figure 21. North America Neuroblastoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Neuroblastoma Treatment Market Share by Country (2020-2031)

Figure 23. United States Neuroblastoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Neuroblastoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Neuroblastoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Neuroblastoma Treatment Market Share by Country (2020-2031)

Figure 27. Germany Neuroblastoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Neuroblastoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Neuroblastoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Neuroblastoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Neuroblastoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Neuroblastoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Neuroblastoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Neuroblastoma Treatment Market Share by Region (2020-2031)

Figure 35. China Neuroblastoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Neuroblastoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Neuroblastoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Neuroblastoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Neuroblastoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Neuroblastoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Neuroblastoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Neuroblastoma Treatment Market Share by Country (2020-2031)

Figure 43. Mexico Neuroblastoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Neuroblastoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Neuroblastoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Neuroblastoma Treatment Market Share by Country (2020-2031)

Figure 47. Turkey Neuroblastoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Neuroblastoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Neuroblastoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Seattle Children’s Revenue Growth Rate in Neuroblastoma Treatment Business (2020-2025)

Figure 51. CureSearch Revenue Growth Rate in Neuroblastoma Treatment Business (2020-2025)

Figure 52. Texas Children’s Revenue Growth Rate in Neuroblastoma Treatment Business (2020-2025)

Figure 53. NANT Revenue Growth Rate in Neuroblastoma Treatment Business (2020-2025)

Figure 54. Sino Biopharmaceutical Revenue Growth Rate in Neuroblastoma Treatment Business (2020-2025)

Figure 55. Jiangsu Hengrui Medicine Co.,Ltd. Revenue Growth Rate in Neuroblastoma Treatment Business (2020-2025)

Figure 56. Fosun Pharmaceutical Revenue Growth Rate in Neuroblastoma Treatment Business (2020-2025)

Figure 57. Novartis Revenue Growth Rate in Neuroblastoma Treatment Business (2020-2025)

Figure 58. Juno Therapeutics Revenue Growth Rate in Neuroblastoma Treatment Business (2020-2025)

Figure 59. Kite Pharma Revenue Growth Rate in Neuroblastoma Treatment Business (2020-2025)

Figure 60. Adaptimmune Revenue Growth Rate in Neuroblastoma Treatment Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Neuroblastoma Drugs Market Research Report 2024

Global Neuroblastoma Chemotherapy Drugs Market Research Report 2025

Global Orthopedic Oncology Treatment Market Insights Forecast to 2030

Global Brain Tumor Diagnosis and Therapeutics Market Insights Forecast to 2030

Global Solid Tumor Cancer Treatment Market Insights Forecast to 2030

Global Stem Cell Treatments Market Insights Forecast to 2030

Immunotherapy Drugs for Neuroblastoma Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Immunotherapy for Neuroblastoma Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Neurofibromatosis Treatment Drug Market Insights Forecast to 2030

Global Cancer Infusion Therapy Market Insights Forecast to 2030

Retinoblastoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Blood and Bone Marrow Cancer Treatment Market Insights Forecast to 2030

Global Chemotherapy Drug Market Insights Forecast to 2030

Global Neuropathic Pain Management Market Insights Forecast to 2030

Global Cancer Pain Market Insights Forecast to 2030

Global Neurorehabilitation Therapy Market Insights Forecast to 2030

Global Immuno oncology Therapy Market Insights Forecast to 2030

Global Stem Cell Therapy Market Insights Forecast to 2030

Global Cancer Biotherapy Market Insights Forecast to 2030

RELATED REPORTS

Global Fixation Device for Radiotherapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4H16852

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Group A Streptococcus for Injection Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-37K16619

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Boron Neutron Capture Therapy System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30U16301

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Radioactive Glass Microsphere Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-2G16953

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions